Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile
Authors:
Top Cited Papers
- 27 May 2023
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 120, 110368
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Anhui Provincial Department of Science and Technology
This publication has 56 references indexed in Scilit:
- Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancerScience, 2015
- Tumor-Derived Osteopontin Reprograms Normal Mammary Fibroblasts to Promote Inflammation and Tumor Growth in Breast CancerCancer Research, 2015
- Genetic Basis for Clinical Response to CTLA-4 Blockade in MelanomaNew England Journal of Medicine, 2014
- PD-1 blockade induces responses by inhibiting adaptive immune resistanceNature, 2014
- Molecular mechanisms of T cell co-stimulation and co-inhibitionNature Reviews Immunology, 2013
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference reportThe Lancet Oncology, 2012
- Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves OutcomeThe American Journal of Medicine, 2008
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005